Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher Inks Collaboration with University of Birmingham for Proteomic, Metabolomic Research

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific said yesterday that it has formed a technology alliance with the University of Birmingham, UK.

Under the partnership, the company will work with university researchers on high-resolution accurate mass and triple quadrupole liquid chromatography mass spectrometry for applications in proteomics and metabolomics.

Birmingham researcher Helen Cooper will lead the proteomics work, which will focus on using high-resolution mass spec and gas-phase ion chemistry for top-down and bottom-up analysis of proteins.

The metabolomics efforts will be led by Birmingham professors Mark Viant and Warwick Dunn and will aim to develop and test new hardware and software approaches for metabolite detection and identification in environmental and clinical research.

With the signing of the agreement, the university becomes Thermo Fisher's first Technology Alliance partner in Europe.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.